Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
04 2019
Historique:
received: 25 07 2018
accepted: 22 11 2018
pubmed: 1 12 2018
medline: 30 1 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

The reliability of initial high-sensitivity cardiac troponin T (hs-cTnT) under limit-of-detection in ruling-out short- and long-term acute coronary events in subjects for suspected non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is not definitely settled. In a retrospective chart review analysis, 1001 subjects with hs-cTnT ≤ 14 ng/L out of 4053 subjects with hs-cTnT measured at Emergency Department (ED) presentation were recruited. The main outcome measure is fatal or non-fatal myocardial infarction (MI) within 30 days; secondary outcomes are MI or major acute coronary events (MACE) as a combination of MI or re-hospitalization for unstable angina within 1 year. In subjects with hs-cTnT < 5 ng/L [32.6% of cases, mean age 63 years (interquartile range 23)], no cases (0%, NPV 100%) had MI within 30 days, 2 cases (0.6%, NPV 99.4%) MI at 1-year, and 11 cases (3.4%, NPV 96.6%) MACE at 1-year. Patients with hs-cTnT < 5 ng/L would have benefited from a shortened decision (9.30 h and 53% overnight ED stay saved). Hs-cTnT < 5 ng/L is confirmed as safe for patients and comfortable for physicians in ruling out MI or MACE both at short and long term, suggesting that a sizable number of patients can be rapidly discharged without unnecessary diagnostic tests and ED observation.

Identifiants

pubmed: 30499074
doi: 10.1007/s11739-018-1996-6
pii: 10.1007/s11739-018-1996-6
doi:

Substances chimiques

Biomarkers 0
Troponin T 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-410

Commentaires et corrections

Type : CommentIn

Références

CJEM. 2001 Apr;3(2):89-94
pubmed: 17610796
Ann Emerg Med. 2016 Jul;68(1):76-87.e4
pubmed: 26794254
Lancet. 2015 Dec 19;386(10012):2481-8
pubmed: 26454362
JAMA Intern Med. 2014 Jan;174(1):51-8
pubmed: 24100783
Eur Heart J. 2012 Sep;33(18):2252-7
pubmed: 22723599
Acad Emerg Med. 2017 Oct;24(10):1267-1277
pubmed: 28544100
N Z Med J. 2015 Jan 30;128(1408):62-71
pubmed: 25662380
J Am Coll Cardiol. 2014 Jun 17;63(23):2569-2578
pubmed: 24694529
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Int J Cardiol. 2013 Jul 1;166(3):752-4
pubmed: 23084108
Eur J Emerg Med. 2016 Apr;23(2):95-101
pubmed: 25536392
BMJ Open. 2017 Jun 9;7(6):e013653
pubmed: 28601817
Circulation. 2016 Nov 15;134(20):1532-1541
pubmed: 27754881
Crit Care. 2011 Jun 10;15(3):R147
pubmed: 21663627
N Engl J Med. 2009 Aug 27;361(9):858-67
pubmed: 19710484
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Clin Chem. 2010 Feb;56(2):254-61
pubmed: 19959623
J Am Coll Cardiol. 2009 Jun 30;54(1):60-8
pubmed: 19555842
Circulation. 2017 Apr 25;135(17):1586-1596
pubmed: 28034899
Acad Emerg Med. 2016 Sep;23(9):1004-13
pubmed: 27178492
Clin Chem. 2015 May;61(5):744-51
pubmed: 25737534
Am J Cardiol. 2016 Dec 1;118(11):1631-1635
pubmed: 27665208
J Am Coll Cardiol. 2011 Sep 20;58(13):1332-9
pubmed: 21920261
Ann Intern Med. 2012 Jun 5;156(11):785-95, W-270, W-271, W-272, W-273, W-274, W-275, W-276, W-277,
pubmed: 22312131
Clin Chem. 2016 Aug;62(8):1115-9
pubmed: 27324737
Arch Intern Med. 2003 Oct 27;163(19):2345-53
pubmed: 14581255
J Am Coll Cardiol. 2012 Jun 5;59(23):2091-8
pubmed: 22578923
Clin Chem Lab Med. 2016 Oct 1;54(10):e279-80
pubmed: 27026711
Clin Chem. 2015 Jul;61(7):983-9
pubmed: 25979953
Heart. 2011 Feb;97(3):190-6
pubmed: 20884788
JAMA Cardiol. 2016 Jul 1;1(4):405-12
pubmed: 27438316
Am J Emerg Med. 2013 Sep;31(9):1302-8
pubmed: 23816196
Ann Emerg Med. 2016 Dec;68(6):649-658.e3
pubmed: 27471140

Auteurs

Andrea Fabbri (A)

Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy. andrea.fabbri@auslromagna.it.

Cristina Bachetti (C)

Dipartimento Cardio-vascolare, Presidio Ospedaliero Morgagni-Pierantoni, AUSL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.

Filippo Ottani (F)

Dipartimento Cardio-vascolare, Presidio Ospedaliero Morgagni-Pierantoni, AUSL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.
Cardiovascular Research Unit, Fondazione Cardiologica Sacco, 47121, Forlì, FC, Italy.

Alice Morelli (A)

Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.

Barbara Benazzi (B)

Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.

Sergio Spiezia (S)

Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.

Marco Cortigiani (M)

Dipartimento Emergenza, Presidio Ospedaliero Morgagni-Pierantoni, Azienda USL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.

Romolo Dorizzi (R)

Laboratorio Unico AUSL della Romagna, Piazzale della Liberazione 60, Pievesestina di Cesena, FC, Italy.

Allan S Jaffe (AS)

Cardiovascular Department and Department of Laboratory Medicine and Pathology, Mayo Clinic and Medical School, 200 First St. SW, Rochester, MN, 55905, USA.

Marcello Galvani (M)

Dipartimento Cardio-vascolare, Presidio Ospedaliero Morgagni-Pierantoni, AUSL della Romagna, Via C Forlanini 34, 47121, Forlì, FC, Italy.
Cardiovascular Research Unit, Fondazione Cardiologica Sacco, 47121, Forlì, FC, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH